Key Takeaways & Executive Findings
- •• 3D-printed exoskeletons improve hand function, activity, and participation in stroke patients, with effects varying by Brunnstrom stage. • Four types of exoskeletons (assistive, corrective, training-oriented, compensatory) are matched to specific Brunnstrom stages for optimal rehabilitation. • Interventions ranged from 15-90 minutes per session, 3-7 times per week, over 5-8 weeks, delivered in institution, home, or combined settings. • 3D printing technology enables personalized adaptation, improving wearability, comfort, usability, and suitability for home-based rehabilitation.
Abstract
OBJECTIVE: To systematically evaluate the clinical efficacy of different types of 3D-printed exoskeletons in hand function rehabilitation for stroke patients based on the International Classification of Functioning, Disability and Health framework. METHODS: A comprehensive search was conducted in PubMed, Cochrane Library, Web of Science, Embase, CNKI, and CBM databases for literature published between January 2015 and December 2024 on 3D-printed exoskeleton interventions for post-stroke hand function rehabilitation. Two researchers independently screened studies, extracted data, and assessed methodological quality following the PRISMA guidelines for systematic reviews. RESULTS: A total of 13 studies involving 62 stroke patients from the United States, China, the Netherlands, Italy, Singapore, and Turkey were finally included. Based on the Brunnstrom stages, exoskeletons were categorized into four types: assistive (Stage I), corrective (Stages II–III), training-oriented (Stages IV–VI), and compensatory (Stages IV–VI). Interventions were delivered via institution-based, home-based, or combined institution-home rehabilitation, with session durations ranging from 15 to 90 minutes, frequencies of 3 to 7 sessions per week, and durations of 5 to 8 weeks. Results showed that assistive exoskeletons improved fine hand use and self-care; corrective exoskeletons improved joint mobility, muscle tone, grip strength, and fine hand use; training-oriented exoskeletons improved joint mobility, upper limb muscle strength, and self-care; compensatory exoskeletons enhanced fine hand use and hand and arm use. CONCLUSION: Based on the ICF framework, evidence indicates that 3D-printed exoskeletons improve hand function, activity, and participation in stroke patients. It is recommended to select matching exoskeleton types according to Brunnstrom stages and develop individualized intervention plans to achieve optimal rehabilitation outcomes.
1. Introduction
According to the China Stroke Center Report 2022, the number of stroke patients aged over 40 in China reached 17.8 million in 2020, with approximately 2.2 million patients experiencing varying degrees of functional impairment [1]. Hand function rehabilitation has become a core challenge in post-stroke motor recovery, with 38% of patients exhibiting significant hand dysfunction at 3 months post-onset and 30%-66% not fully recovering by 6 months, severely impacting daily living and quality of life [2-3]. For hand rehabilitation, end-effector robots can improve proximal joint motor function but have notable limitations in distal joint movement and tactile feedback during object manipulation; clinical studies have confirmed their limited overall upper limb functional recovery [4-6]. In contrast, wearable exoskeletons are highly compatible with human anatomy, and through precise torque control can effectively promote muscle strength rebuilding, joint range of motion recovery, and motor coordination, while supporting high-intensity task-oriented training and significantly reducing therapist workload [7-8].
Traditional exoskeletons are limited by generalized design concepts, with standardized architectures that fail to adapt to individual hand structure differences or injury types, and are costly and poorly portable, failing to meet home rehabilitation needs [9-11]. In contrast, 3D printing technology, through the synergy of digital modeling and additive manufacturing, significantly enhances the adaptability of exoskeletons to patients' specific anatomical needs, offering customization, cost-effectiveness, and rapid prototyping capabilities [12-15].
Numerous systematic reviews have confirmed the positive effects of upper limb robot-assisted training on upper limb functional recovery in stroke patients [16-18]. However, the clinical application of 3D-printed exoskeletons for hand function rehabilitation still faces multiple challenges: heterogeneity in outcome assessment systems, lack of comparability across different functional assessment tools, making objective comparison of exoskeleton performance difficult; standardized treatment protocols have not been established, and optimal training intensity, frequency, and duration require large-scale clinical validation [19]. This study, based on the International Classification of Functioning, Disability and Health (ICF) framework, constructs a standardized assessment system [20], and uses the Brunnstrom recovery staging theory to build a matching model between functional recovery stages and exoskeleton types [21], systematically analyzing patients' differential responses to different types of exoskeleton interventions, aiming to provide a theoretical basis for individualized rehabilitation plans and promote the development of rehabilitation engineering towards universal accessibility and verifiable efficacy, thereby improving the quality of life for stroke patients.
Loading authentic research manuscript (Pages 1–5)...
Tang Ya, Li Long, Huang Du, Huang Zhaolu (2026). Systematic review of the effect of 3D-printed exoskeleton on hand function rehabilitation in stroke patients. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21425
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are the main types of 3D-printed exoskeletons for hand rehabilitation in stroke patients?
Based on Brunnstrom stages, 3D-printed exoskeletons are categorized into four types: assistive (Stage I), corrective (Stages II-III), training-oriented (Stages IV-VI), and compensatory (Stages IV-VI). Each type targets specific functional deficits and rehabilitation goals.
How effective are 3D-printed exoskeletons in improving hand function after stroke?
The systematic review found that 3D-printed exoskeletons improve hand function, activity, and participation in stroke patients. Effects vary by type: assistive exoskeletons improve fine hand use and self-care; corrective improve joint mobility, muscle tone, grip strength, and fine hand use; training-oriented improve joint mobility, muscle strength, and self-care; compensatory improve fine hand use and hand/arm use.
What is the recommended intervention protocol for 3D-printed exoskeleton training?
Interventions in the reviewed studies ranged from 15 to 90 minutes per session, 3 to 7 times per week, over 5 to 8 weeks. Delivery settings included institution-based, home-based, or combined institution-home rehabilitation. Individualized protocols based on Brunnstrom stage are recommended.
How does 3D printing technology benefit exoskeleton design for stroke rehabilitation?
3D printing enables personalized adaptation to patients' biomechanical characteristics, improving ease of donning/doffing, wearing comfort, usability, size fit, weight optimization, and customization. This supports home-based rehabilitation and enhances patient compliance.
What are the future research directions for 3D-printed exoskeletons in stroke rehabilitation?
Future research should explore multi-degree-of-freedom designs to improve joint mobility, optimize movement patterns to enhance muscle strength, and investigate combined interventions to address muscle tone abnormalities. Large-scale clinical trials are needed to establish standardized protocols.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.